The path to healthy ageing in China: a Peking University–Lancet Commission

X Chen, J Giles, Y Yao, W Yip, Q Meng, L Berkman… - The Lancet, 2022 - thelancet.com
Executive summary Around the world, populations are ageing at a faster pace than in the
past and this demographic transition will have effects on all aspects of societies. In May …

China stroke surveillance report 2021

WJ Tu, LD Wang - Military Medical Research, 2023 - Springer
Since 2015, stroke has become the leading cause of death and disability in China, posing a
significant threat to the health of its citizens as a major chronic non-communicable disease …

Estimated burden of stroke in China in 2020

WJ Tu, Z Zhao, P Yin, L Cao, J Zeng, H Chen… - JAMA network …, 2023 - jamanetwork.com
Importance Stroke is the leading cause of death in China. However, recent data about the up-
to-date stroke burden in China are limited. Objective To investigate the urban-rural disparity …

China stroke statistics: an update on the 2019 report from the national center for healthcare quality management in neurological diseases, China national clinical …

YJ Wang, ZX Li, HQ Gu, Y Zhai, Q Zhou… - Stroke and vascular …, 2022 - svn.bmj.com
China faces the greatest challenge from stroke in the world. According to results from the
Global Burden of Disease Study 2019, there were 3.94 million new stroke cases, 28.76 …

Prevalence of stroke in China, 2013–2019: a population-based study

WJ Tu, Y Hua, F Yan, H Bian, Y Yang, M Lou… - The Lancet Regional …, 2022 - thelancet.com
Background The stroke burden in China has increased during the past 40 years. The
present study aimed to determine the recent trends in the prevalence of stroke from 2013 to …

Global, regional, and national burden of ischemic stroke, 1990–2021: an analysis of data from the global burden of disease study 2021

X Li, X Kong, C Yang, Z Cheng, J Lv, H Guo… - EClinicalMedicine, 2024 - thelancet.com
Background Ischemic stroke remains a major contributor to global mortality and morbidity.
This study aims to provide an updated assessment of rates in ischemic stroke prevalence …

Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy

S Li, Z Liu, P Joseph, B Hu, L Yin, LA Tse… - European Heart …, 2022 - academic.oup.com
Aims To examine the incidence of cardiovascular disease (CVD) and mortality in China and
in key subpopulations, and to estimate the population-level risks attributable to 12 common …

Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey

M Zhang, Y Shi, B Zhou, Z Huang, Z Zhao, C Li… - Bmj, 2023 - bmj.com
Objective To assess the recent trends in prevalence and management of hypertension in
China, nationally and by population subgroups. Design Six rounds of a national survey …

Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke

ZH Zhu, F Jia, W Ahmed, GL Zhang… - Neural Regeneration …, 2023 - journals.lww.com
Our previous study demonstrated the potential therapeutic role of human neural stem cell-
derived exosomes (hNSC-Exo) in ischemic stroke. Here, we loaded brain-derived …

Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham …

C Hou, J Lan, Y Lin, H Song, Y Wang, W Zhao… - The Lancet …, 2022 - thelancet.com
Background Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes
of stroke worldwide, and it is associated with a high risk of recurrent stroke with currently …